AMPHASTAR-IMS

AMPHADASE

Manufacturer:

AMPHASTAR-IMS

Amphadase HCPCS:

J3470

HCPCS Code Descriptor:

Injection, hyaluronidase, up to 150 units

Category:

J Code

Amphadase NDCs:

00548-9090-10

Primary Type:

Enzyme Replacement Therapy

Generic/Specialty Status:

Single-Source

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00548-9090-10

About Amphadase:

AMPHADASE is a Enzyme Replacement Therapy drug manufactured by AMPHASTAR-IMS and administered via the Subcutaneous route of administration. The J Code: J3470 is aligned to the drug AMPHADASE.

ACCESS PRICING AND MORE BY REGISTERING

J3470 Added Date:

January 1, 1982

J3470 Effective Date:

January 1, 1997

J3470 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Amphadase billing and coding information.
Our team did not identify a source for Amphadase patient assistance information. Please reach out to our team if you feel that this is a mistake.
AMPHADASE prescribing information can be found at the link below:
Information regarding AMPHADASE’s side effects can be found at MedlinePlus